Regulators of hepcidin expression

Vitamins and Hormones

Volumn 110, Issue , 2019, Pages 101-129

  Roth, Marie Paule ^a   Meynard, Delphine ^a   Coppin, Hélène ^a  

^a UMR 1220 TCEM (INRA ENITAB)   (France)

Author keywords

Erythropoiesis; Hepcidin; Hypoxia; Inflammation; Iron; Testosterone

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEPCIDIN; IRON;

ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IRON METABOLISM DISORDER; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; GENE EXPRESSION REGULATION; HEPCIDINS; HUMANS; IRON; IRON METABOLISM DISORDERS; SIGNAL TRANSDUCTION;

EID: 85060865432     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2019.01.005     Document Type: Chapter

References (128)

1. Ali, S., Singh, N.N., Yildirim, H., Ramji, D.P., Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes. The International Journal of Biochemistry & Cell Biology 42:1 (2010), 113–119, 10.1016/j.biocel.2009.09.018.
2. Anderson, G.J., Frazer, D.M., Iron metabolism meets signal transduction. Nature Genetics 38:5 (2006), 503–504.
3. Andriopoulos, B. Jr., Corradini, E., Xia, Y., Faasse, S.A., Chen, S., Grgurevic, L., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nature Genetics 41:4 (2009), 482–487.
4. Armitage, A.E., Eddowes, L.A., Gileadi, U., Cole, S., Spottiswoode, N., Selvakumar, T.A., et al. Hepcidin regulation by innate immune and infectious stimuli. Blood 118:15 (2011), 4129–4139, 10.1182/blood-2011-04-351957.
5. Babitt, J.L., Zhang, Y., Samad, T.A., Xia, Y., Tang, J., Campagna, J.A., et al. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. The Journal of Biological Chemistry 280:33 (2005), 29820–29827.
6. Babitt, J.L., Huang, F.W., Wrighting, D.M., Xia, Y., Sidis, Y., Samad, T.A., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genetics 38:5 (2006), 531–539.
7. Babitt, J.L., Huang, F.W., Xia, Y., Sidis, Y., Andrews, N.C., Lin, H.Y., Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. The Journal of Clinical Investigation 117:7 (2007), 1933–1939.
8. Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., et al. Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis. The Journal of Clinical Endocrinology and Metabolism 95:10 (2010), 4743–4747.
9. Besson-Fournier, C., Latour, C., Kautz, L., Bertrand, J., Ganz, T., Roth, M.P., et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120:2 (2012), 431–439.
10. Besson-Fournier, C., Gineste, A., Latour, C., Gourbeyre, O., Meynard, D., Martin, P., et al. Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B. Blood 129:4 (2017), 533–536, 10.1182/blood-2016-10-748541.
11. Bode, J.G., Albrecht, U., Haussinger, D., Heinrich, P.C., Schaper, F., Hepatic acute phase proteins—Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. European Journal of Cell Biology 91:6–7 (2012), 496–505, 10.1016/j.ejcb.2011.09.008.
12. Calof, O.M., Singh, A.B., Lee, M.L., Kenny, A.M., Urban, R.J., Tenover, J.L., et al. Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 60:11 (2005), 1451–1457.
13. Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genetics 25:1 (2000), 14–15.
14. Campbell, J.S., Prichard, L., Schaper, F., Schmitz, J., Stephenson-Famy, A., Rosenfeld, M.E., et al. Expression of suppressors of cytokine signaling during liver regeneration. The Journal of Clinical Investigation 107:10 (2001), 1285–1292, 10.1172/JCI11867.
15. Canali, S., Core, A.B., Zumbrennen-Bullough, K.B., Merkulova, M., Wang, C.Y., Schneyer, A.L., et al. Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology 157:3 (2016), 1146–1162, 10.1210/en.2015-1747.
16. Canali, S., Wang, C.Y., Zumbrennen-Bullough, K.B., Bayer, A., Babitt, J.L., Bmp2 controls iron homeostasis in mice independent of Bmp6. American Journal of Hematology 92:11 (2017), 1204–1213, 10.1002/ajh.24888.
17. Canali, S., Zumbrennen-Bullough, K.B., Core, A.B., Wang, C.Y., Nairz, M., Bouley, R., et al. Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood 129:4 (2017), 405–414, 10.1182/blood-2016-06-721571.
18. Cantwell, C.A., Sterneck, E., Johnson, P.F., Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1. Molecular and Cellular Biology 18:4 (1998), 2108–2117.
19. Chung, B., Verdier, F., Matak, P., Deschemin, J.C., Mayeux, P., Vaulont, S., Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone. The FASEB Journal 24:6 (2010), 2093–2103.
20. Corradini, E., Meynard, D., Wu, Q., Chen, S., Ventura, P., Pietrangelo, A., et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54:1 (2011), 273–284, 10.1002/hep.24359.
21. Corradini, E., Rozier, M., Meynard, D., Odhiambo, A., Lin, H.Y., Feng, Q., et al. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 141:5 (2011), 1907–1914, 10.1053/j.gastro.2011.06.077.
22. Coviello, A.D., Kaplan, B., Lakshman, K.M., Chen, T., Singh, A.B., Bhasin, S., Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. The Journal of Clinical Endocrinology and Metabolism 93:3 (2008), 914–919.
23. Croker, B.A., Krebs, D.L., Zhang, J.G., Wormald, S., Willson, T.A., Stanley, E.G., et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nature Immunology 4:6 (2003), 540–545, 10.1038/ni931.
24. D'Alessio, F., Hentze, M.W., Muckenthaler, M.U., The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation. Journal of Hepatology 57:5 (2012), 1052–1060, 10.1016/j.jhep.2012.06.015.
25. Derynck, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:6958 (2003), 577–584, 10.1038/nature02006.
26. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S.J., Moynihan, J., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403:6771 (2000), 776–781.
27. Ehlting, C., Lai, W.S., Schaper, F., Brenndorfer, E.D., Matthes, R.J., Heinrich, P.C., et al. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. Journal of Immunology 178:5 (2007), 2813–2826.
28. Enns, C.A., Ahmed, R., Wang, J., Ueno, A., Worthen, C., Tsukamoto, H., et al. Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway. PLoS One, 8(4), 2013, e60534, 10.1371/journal.pone.0060534.
29. Escobar-Morreale, H.F., Iron metabolism and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism 23:10 (2012), 509–515.
30. Feder, J.N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D.A., Basava, A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 13:4 (1996), 399–408.
31. Feng, Q., Migas, M.C., Waheed, A., Britton, R.S., Fleming, R.E., Ferritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 302:12 (2012), G1397–G1404, 10.1152/ajpgi.00020.2012.
32. Finberg, K.E., Heeney, M.M., Campagna, D.R., Aydinok, Y., Pearson, H.A., Hartman, K.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nature Genetics 40:5 (2008), 569–571, 10.1038/ng.130.
33. Finberg, K.E., Whittlesey, R.L., Fleming, M.D., Andrews, N.C., Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115:18 (2010), 3817–3826, 10.1182/blood-2009-05-224808.
34. Frydlova, J., Prikryl, P., Truksa, J., Falke, L.L., Du, X., Gurieva, I., et al. Effect of erythropoietin, iron deficiency and iron overload on liver matriptase-2 (TMPRSS6) protein content in mice and rats. PLoS One, 11(2), 2016, e0148540, 10.1371/journal.pone.0148540.
35. Ganz, T., Systemic iron homeostasis. Physiological Reviews 93:4 (2013), 1721–1741, 10.1152/physrev.00008.2013.
36. Ganz, T., Iron and infection. International Journal of Hematology 107:1 (2018), 7–15, 10.1007/s12185-017-2366-2.
37. Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.S., Enns, C.A., Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metabolism 9:3 (2009), 217–227.
38. Gardenghi, S., Renaud, T.M., Meloni, A., Casu, C., Crielaard, B.J., Bystrom, L.M., et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123:8 (2014), 1137–1145, 10.1182/blood-2013-08-521625.
39. Goldstein, I., Paakinaho, V., Baek, S., Sung, M.H., Hager, G.L., Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Nature Communications, 8(1), 2017, 1849, 10.1038/s41467-017-02055-5.
40. Goodnough, J.B., Ramos, E., Nemeth, E., Ganz, T., Inhibition of hepcidin transcription by growth factors. Hepatology 56:1 (2012), 291–299.
41. Goswami, T., Andrews, N.C., Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. The Journal of Biological Chemistry 281:39 (2006), 28494–28498.
42. Guo, W., Bachman, E., Li, M., Roy, C.N., Blusztajn, J., Wong, S., et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 12:2 (2013), 280–291, 10.1111/acel.12052.
43. Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., et al. Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. The Journal of Clinical Investigation 123:4 (2013), 1531–1541, 10.1172/JCI66969.
44. Guo, W., Schmidt, P.J., Fleming, M.D., Bhasin, S., Effects of testosterone on erythropoiesis in a female mouse model of anemia of inflammation. Endocrinology 157:7 (2016), 2937–2946, 10.1210/en.2016-1150.
45. Gutschow, P., Schmidt, P.J., Han, H., Ostland, V., Bartnikas, T.B., Pettiglio, M.A., et al. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: Correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis. Haematologica 100:2 (2015), 167–177, 10.3324/haematol.2014.116723.
46. Harrison-Findik, D.D., Gender-related variations in iron metabolism and liver diseases. World Journal of Hepatology 2:8 (2010), 302–310.
47. He, G., Karin, M., NF-kappaB and STAT3—Key players in liver inflammation and cancer. Cell Research 21:1 (2011), 159–168, 10.1038/cr.2010.183.
48. Healey, E.G., Bishop, B., Elegheert, J., Bell, C.H., Padilla-Parra, S., Siebold, C., Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein. Nature Structural & Molecular Biology 22:6 (2015), 458–465, 10.1038/nsmb.3016.
49. Hou, Y., Zhang, S., Wang, L., Li, J., Qu, G., He, J., et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 511:2 (2012), 398–403, 10.1016/j.gene.2012.09.060.
50. Ikeda, Y., Tajima, S., Izawa-Ishizawa, Y., Kihira, Y., Ishizawa, K., Tomita, S., et al. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One, 7(7), 2012, e40465, 10.1371/journal.pone.0040465.
51. Isaacs, M.J., Kawakami, Y., Allendorph, G.P., Yoon, B.H., Izpisua Belmonte, J.C., Choe, S., Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly. Molecular Endocrinology 24:7 (2010), 1469–1477, 10.1210/me.2009-0496.
52. Kanamori, Y., Sugiyama, M., Hashimoto, O., Murakami, M., Matsui, T., Funaba, M., Regulation of hepcidin expression by inflammation-induced activin B. Scientific Reports, 6, 2016, 38702, 10.1038/srep38702.
53. Kanamori, Y., Murakami, M., Sugiyama, M., Hashimoto, O., Matsui, T., Funaba, M., Interleukin-1beta (IL-1beta) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein delta (C/EBPdelta) expression in hepatocytes. The Journal of Biological Chemistry 292:24 (2017), 10275–10287, 10.1074/jbc.M116.770974.
54. Kanda, J., Uchiyama, T., Tomosugi, N., Higuchi, M., Uchiyama, T., Kawabata, H., Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines. International Journal of Hematology 90:5 (2009), 545–552, 10.1007/s12185-009-0443-x.
55. Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R.H., et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112:4 (2008), 1503–1509, 10.1182/blood-2008-03-143354.
56. Kautz, L., Meynard, D., Besson-Fournier, C., Darnaud, V., Al Saati, T., Coppin, H., et al. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 114:12 (2009), 2515–2520, 10.1182/blood-2009-02-206771.
57. Kautz, L., Jung, G., Nemeth, E., Ganz, T., Erythroferrone contributes to recovery from anemia of inflammation. Blood 124:16 (2014), 2569–2574, 10.1182/blood-2014-06-584607.
58. Kautz, L., Jung, G., Valore, E.V., Rivella, S., Nemeth, E., Ganz, T., Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics 46:7 (2014), 678–684, 10.1038/ng.2996.
59. Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., et al. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood 126:17 (2015), 2031–2037, 10.1182/blood-2015-07-658419.
60. Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., Swinkels, D., Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:5 (2005), 1864–1866.
61. Kim, S.W., Hwang, J.H., Cheon, J.M., Park, N.S., Park, S.E., Park, S.J., et al. Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. Journal of Korean Medical Science 20:3 (2005), 409–416.
62. Kim, A., Fung, E., Parikh, S.G., Valore, E.V., Gabayan, V., Nemeth, E., et al. A mouse model of anemia of inflammation: Complex pathogenesis with partial dependence on hepcidin. Blood 123:8 (2014), 1129–1136, 10.1182/blood-2013-08-521419.
63. Koch, P.S., Olsavszky, V., Ulbrich, F., Sticht, C., Demory, A., Leibing, T., et al. Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood 129:4 (2017), 415–419, 10.1182/blood-2016-07-729822.
64. Krijt, J., Fujikura, Y., Ramsay, A.J., Velasco, G., Necas, E., Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6). Blood Cells, Molecules & Diseases 47:2 (2011), 133–137, 10.1016/j.bcmd.2011.04.009.
65. Kubo, M., Hanada, T., Yoshimura, A., Suppressors of cytokine signaling and immunity. Nature Immunology 4:12 (2003), 1169–1176, 10.1038/ni1012.
66. Latour, C., Kautz, L., Besson-Fournier, C., Island, M.L., Canonne-Hergaux, F., Loreal, O., et al. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology 59:2 (2014), 683–694, 10.1002/hep.26648.
67. Latour, C., Besson-Fournier, C., Meynard, D., Silvestri, L., Gourbeyre, O., Aguilar-Martinez, P., et al. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology 63:1 (2016), 126–137, 10.1002/hep.28254.
68. Latour, C., Besson-Fournier, C., Gourbeyre, O., Meynard, D., Roth, M.P., Coppin, H., Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge. Blood 130:21 (2017), 2339–2343, 10.1182/blood-2017-07-795658.
69. Lee, P., Peng, H., Gelbart, T., Beutler, E., The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 101:25 (2004), 9263–9265.
70. Lee, P., Peng, H., Gelbart, T., Wang, L., Beutler, E., Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proceedings of the National Academy of Sciences of the United States of America 102:6 (2005), 1906–1910.
71. Lehtihet, M., Bonde, Y., Beckman, L., Berinder, K., Hoybye, C., Rudling, M., et al. Circulating hepcidin-25 is reduced by endogenous estrogen in humans. PLoS One, 11(2), 2016, e0148802, 10.1371/journal.pone.0148802.
72. Lesbordes-Brion, J.C., Viatte, L., Bennoun, M., Lou, D.Q., Ramey, G., Houbron, C., et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108:4 (2006), 1402–1405.
73. Liu, Q., Davidoff, O., Niss, K., Haase, V.H., Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. The Journal of Clinical Investigation 122:12 (2012), 4635–4644, 10.1172/JCI63924.
74. Liu, X., Hubchak, S.C., Browne, J.A., Schnaper, H.W., Epidermal growth factor inhibits transforming growth factor-beta-induced fibrogenic differentiation marker expression through ERK activation. Cellular Signalling 26:10 (2014), 2276–2283, 10.1016/j.cellsig.2014.05.018.
75. Luque-Ramirez, M., Alvarez-Blasco, F., Alpanes, M., Escobar-Morreale, H.F., Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 96:3 (2011), 846–852.
76. Mastrogiannaki, M., Matak, P., Mathieu, J.R., Delga, S., Mayeux, P., Vaulont, S., et al. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica 97:6 (2012), 827–834, 10.3324/haematol.2011.056119.
77. Mayeur, C., Leyton, P.A., Kolodziej, S.A., Yu, B., Bloch, K.D., BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism. Blood 124:13 (2014), 2116–2123, 10.1182/blood-2014-04-572644.
78. Mayeur, C., Lohmeyer, L.K., Leyton, P., Kao, S.M., Pappas, A.E., Kolodziej, S.A., et al. The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6. Blood 123:14 (2014), 2261–2268, 10.1182/blood-2013-02-480095.
79. McKie, A.T., Weher, K., Brennan, K., Farzaneh, F., Peters, T.J., Hentze, M.W., et al. A novel IRE containing mRNA predominantly expressed in duodenum and placenta encodes a basolateral membrane protein associated with iron transport., Bioiron’99, Sorrento, May 23–28, 1999.
80. Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., Roth, M.P., Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nature Genetics 41:4 (2009), 478–481.
81. Mueller, T.D., RGM co-receptors add complexity to BMP signaling. Nature Structural & Molecular Biology 22:6 (2015), 439–440, 10.1038/nsmb.3037.
82. Nai, A., Pagani, A., Mandelli, G., Lidonnici, M.R., Silvestri, L., Ferrari, G., et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia. Blood 119:21 (2012), 5021–5029, 10.1182/blood-2012-01-401885.
83. Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., et al. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood 127:19 (2016), 2327–2336, 10.1182/blood-2015-11-681494.
84. Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. The Journal of Clinical Investigation 113:9 (2004), 1271–1276.
85. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:5704 (2004), 2090–2093.
86. Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proceedings of the National Academy of Sciences of the United States of America 98:15 (2001), 8780–8785.
87. Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proceedings of the National Academy of Sciences of the United States of America 99:7 (2002), 4596–4601.
88. Nicolas, G., Chauvet, C., Viatte, L., Danan, J.L., Bigard, X., Devaux, I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. The Journal of Clinical Investigation 110:7 (2002), 1037–1044.
89. Nili, M., Shinde, U., Rotwein, P., Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression. The Journal of Biological Chemistry 285:32 (2010), 24783–24792, 10.1074/jbc.M110.130286.
90. Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y.I., et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. The Journal of Biological Chemistry 277:7 (2002), 5330–5338, 10.1074/jbc.M102750200.
91. Papanikolaou, G., Samuels, M.E., Ludwig, E.H., MacDonald, M.L., Franchini, P.L., Dube, M.P., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics 36:1 (2004), 77–82.
92. Park, C.H., Valore, E.V., Waring, A.J., Ganz, T., Hepcidin, a urinary antimicrobial peptide synthesized in the liver. The Journal of Biological Chemistry 276:11 (2001), 7806–7810.
93. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. The Journal of Biological Chemistry 276:11 (2001), 7811–7819.
94. Ramos, E., Kautz, L., Rodriguez, R., Hansen, M., Gabayan, V., Ginzburg, Y., et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53:4 (2011), 1333–1341, 10.1002/hep.24178.
95. Rausa, M., Pagani, A., Nai, A., Campanella, A., Gilberti, M.E., Apostoli, P., et al. Bmp6 expression in murine liver non parenchymal cells: A mechanism to control their high Iron exporter activity and protect hepatocytes from Iron overload?. PLoS One, 10(4), 2015, e0122696, 10.1371/journal.pone.0122696.
96. Rishi, G., Subramaniam, V.N., The liver in regulation of iron homeostasis. American Journal of Physiology. Gastrointestinal and Liver Physiology 313:3 (2017), G157–G165, 10.1152/ajpgi.00004.2017.
97. Rishi, G., Crampton, E.M., Wallace, D.F., Subramaniam, V.N., In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS One, 8(10), 2013, e77267, 10.1371/journal.pone.0077267.
98. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genetics 33:1 (2003), 21–22.
99. Roy, C.N., Mak, H.H., Akpan, I., Losyev, G., Zurakowski, D., Andrews, N.C., Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109:9 (2007), 4038–4044, 10.1182/blood-2006-10-051755.
100. Schmidt, P.J., Fleming, M.D., Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2. American Journal of Hematology 87:6 (2012), 588–595, 10.1002/ajh.23173.
101. Schmidt, P.J., Toran, P.T., Giannetti, A.M., Bjorkman, P.J., Andrews, N.C., The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metabolism 7:3 (2008), 205–214.
102. Schmidt, P.J., Toudjarska, I., Sendamarai, A.K., Racie, T., Milstein, S., Bettencourt, B.R., et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia. Blood 121:7 (2013), 1200–1208, 10.1182/blood-2012-09-453977.
103. Shahani, S., Braga-Basaria, M., Maggio, M., Basaria, S., Androgens and erythropoiesis: Past and present. Journal of Endocrinological Investigation 32:8 (2009), 704–716.
104. Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J., Camaschella, C., The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metabolism 8:6 (2008), 502–511, 10.1016/j.cmet.2008.09.012.
105. Smith, C.L., Arvedson, T.L., Cooke, K.S., Dickmann, L.J., Forte, C., Li, H.Y., et al. IL-22 regulates iron availability in vivo through the induction of hepcidin. Journal of Immunology 191:4 (2013), 1845–1855, 10.4049/jimmunol.1202716.
106. Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., et al. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut 63:12 (2014), 1951–1959, 10.1136/gutjnl-2013-305317.
107. Steinbicker, A.U., Bartnikas, T.B., Lohmeyer, L.K., Leyton, P., Mayeur, C., Kao, S.M., et al. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood 118:15 (2011), 4224–4230.
108. Steinbicker, A.U., Sachidanandan, C., Vonner, A.J., Yusuf, R.Z., Deng, D.Y., Lai, C.S., et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 117:18 (2011), 4915–4923.
109. Tanno, T., Bhanu, N.V., Oneal, P.A., Goh, S.H., Staker, P., Lee, Y.T., et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Medicine 13:9 (2007), 1096–1101, 10.1038/nm1629.
110. Tanno, T., Porayette, P., Sripichai, O., Noh, S.J., Byrnes, C., Bhupatiraju, A., et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114:1 (2009), 181–186, 10.1182/blood-2008-12-195503.
111. Theurl, I., Schroll, A., Sonnweber, T., Nairz, M., Theurl, M., Willenbacher, W., et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 118:18 (2011), 4977–4984.
112. Trinder, D., Baker, E., Transferrin receptor 2: A new molecule in iron metabolism. The International Journal of Biochemistry & Cell Biology 35:3 (2003), 292–296.
113. Truksa, J., Peng, H., Lee, P., Beutler, E., Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proceedings of the National Academy of Sciences of the United States of America 103:27 (2006), 10289–10293.
114. Valera, E., Isaacs, M.J., Kawakami, Y., Izpisua Belmonte, J.C., Choe, S., BMP-2/6 heterodimer is more effective than BMP-2 or BMP-6 homodimers as inductor of differentiation of human embryonic stem cells. PLoS One, 5(6), 2010, e11167, 10.1371/journal.pone.0011167.
115. Verga Falzacappa, M.V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M.W., Muckenthaler, M.U., STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109:1 (2007), 353–358.
116. Wallace, D.F., Subramaniam, V.N., Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo. International Immunology 27:6 (2015), 281–287, 10.1093/intimm/dxu144.
117. Wallace, D.F., Summerville, L., Crampton, E.M., Frazer, D.M., Anderson, G.J., Subramaniam, V.N., Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50:6 (2009), 1992–2000, 10.1002/hep.23198.
118. Wallace, D.F., McDonald, C.J., Ostini, L., Subramaniam, V.N., Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2. Blood 117:10 (2011), 2960–2966, 10.1182/blood-2010-08-303859.
119. Wallace, D.F., Secondes, E.S., Rishi, G., Ostini, L., McDonald, C.J., Lane, S.W., et al. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. British Journal of Haematology 168:6 (2015), 891–901, 10.1111/bjh.13225.
120. Wang, R.H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metabolism 2:6 (2005), 399–409.
121. Wang, H., Lafdil, F., Kong, X., Gao, B., Signal transducer and activator of transcription 3 in liver diseases: A novel therapeutic target. International Journal of Biological Sciences 7:5 (2011), 536–550.
122. Wang, C.Y., Core, A.B., Canali, S., Zumbrennen-Bullough, K.B., Ozer, S., Umans, L., et al. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. Blood 130:1 (2017), 73–83, 10.1182/blood-2016-12-759423.
123. Wrighting, D.M., Andrews, N.C., Interleukin-6 induces hepcidin expression through STAT3. Blood 108:9 (2006), 3204–3209.
124. Yang, Q., Jian, J., Katz, S., Abramson, S.B., Huang, X., 17beta-estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 153:7 (2012), 3170–3178, 10.1210/en.2011-2045.
125. Yu, P.B., Hong, C.C., Sachidanandan, C., Babitt, J.L., Deng, D.Y., Hoyng, S.A., et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nature Chemical Biology 4:1 (2008), 33–41.
126. Zhang, A.S., Gao, J., Koeberl, D.D., Enns, C.A., The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo. The Journal of Biological Chemistry 285:22 (2010), 16416–16423, 10.1074/jbc.M110.109488.
127. Zhao, N., Nizzi, C.P., Anderson, S.A., Wang, J., Ueno, A., Tsukamoto, H., et al. Low intracellular iron increases the stability of matriptase-2. The Journal of Biological Chemistry 290:7 (2015), 4432–4446, 10.1074/jbc.M114.611913.
128. Zhen, A.W., Nguyen, N.H., Gibert, Y., Motola, S., Buckett, P., Wessling-Resnick, M., et al. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology 58:4 (2013), 1315–1325, 10.1002/hep.26490.